Publication: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
dc.contributor.coauthor | Tasci, Elif Senocak | |
dc.contributor.coauthor | Oyan, Basak | |
dc.contributor.coauthor | Sonmez, Ozlem | |
dc.contributor.coauthor | Mutlu, Arda Ulas | |
dc.contributor.coauthor | Atci, Muhammed Mustafa | |
dc.contributor.coauthor | Sakin, Abdullah | |
dc.contributor.coauthor | Oner, Irem | |
dc.contributor.coauthor | Cinkir, Havva Yesil | |
dc.contributor.coauthor | Eryilmaz, Melek Karakurt | |
dc.contributor.coauthor | Caglayan, Dilek | |
dc.contributor.coauthor | Balcik, Onur Yazdan | |
dc.contributor.coauthor | Paksoy, Nail | |
dc.contributor.coauthor | Karabulut, Senem | |
dc.contributor.coauthor | Salim, Derya Kivrak | |
dc.contributor.coauthor | Bilir, Cemil | |
dc.contributor.coauthor | Ozen, Mirac | |
dc.contributor.coauthor | Ozcelik, Melike | |
dc.contributor.coauthor | Arican, Ali | |
dc.contributor.coauthor | Akagunduz, Baran | |
dc.contributor.coauthor | Inal, Ali | |
dc.contributor.coauthor | Aydin, Dincer | |
dc.contributor.coauthor | Ozer, Leyla | |
dc.contributor.coauthor | Gulmez, Ahmet | |
dc.contributor.coauthor | Turhal, Nazim Serdar | |
dc.contributor.coauthor | Esen, Selin Akturk | |
dc.contributor.coauthor | Algin, Efnan | |
dc.contributor.coauthor | Iriagac, Yakup | |
dc.contributor.coauthor | Sakalar, Teoman | |
dc.contributor.coauthor | Unal, Caglar | |
dc.contributor.coauthor | Er, Ozlem | |
dc.contributor.coauthor | Secmeler, Saban | |
dc.contributor.coauthor | Bozkurt, Mustafa | |
dc.contributor.department | KUH (Koç University Hospital) | |
dc.contributor.kuauthor | Akbaş, Sinem | |
dc.contributor.schoolcollegeinstitute | KUH (KOÇ UNIVERSITY HOSPITAL) | |
dc.date.accessioned | 2024-12-29T09:36:39Z | |
dc.date.issued | 2024 | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 1 | |
dc.description.openaccess | gold, Green Published | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.volume | 24 | |
dc.identifier.doi | 10.1186/s12885-024-11863-0 | |
dc.identifier.eissn | 1471-2407 | |
dc.identifier.quartile | Q2 | |
dc.identifier.scopus | 2-s2.0-85182828807 | |
dc.identifier.uri | https://doi.org/10.1186/s12885-024-11863-0 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/22114 | |
dc.identifier.wos | 1148300200002 | |
dc.keywords | Chemotherapy | |
dc.keywords | Cancer | |
dc.language.iso | eng | |
dc.publisher | BMC | |
dc.relation.ispartof | BMC Cancer | |
dc.subject | Oncology | |
dc.title | Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024) | |
dc.type | Other | |
dc.type.other | Correction | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Akbaş, Sinem | |
local.publication.orgunit1 | KUH (KOÇ UNIVERSITY HOSPITAL) | |
local.publication.orgunit2 | KUH (Koç University Hospital) | |
relation.isOrgUnitOfPublication | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
relation.isOrgUnitOfPublication.latestForDiscovery | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
relation.isParentOrgUnitOfPublication | 055775c9-9efe-43ec-814f-f6d771fa6dee | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 055775c9-9efe-43ec-814f-f6d771fa6dee |